Affinity Asset Advisors, LLC Celldex Therapeutics, Inc. Transaction History

Affinity Asset Advisors, LLC

  • $579 Million
  • Q3 2024

A detailed history of Affinity Asset Advisors, LLC transactions in Celldex Therapeutics, Inc. stock. As of the latest transaction made, Affinity Asset Advisors, LLC holds 125,000 shares of CLDX stock, worth $3.17 Million. This represents 0.73% of its overall portfolio holdings.

Number of Shares
125,000
Previous 475,400 73.71%
Holding current value
$3.17 Million
Previous $17.6 Million 75.87%
% of portfolio
0.73%
Previous 2.39%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
SELL
$32.06 - $44.56 $11.2 Million - $15.6 Million
-350,400 Reduced 73.71%
125,000 $4.25 Million
Q2 2024

Aug 14, 2024
SELL
$32.76 - $42.56 $1.13 Million - $1.47 Million
-34,600 Reduced 6.78%
475,400 $17.6 Million
Q1 2024

May 14, 2024
BUY
$35.22 - $51.88 $3.87 Million - $5.71 Million
110,000 Added 27.5%
510,000 $21.4 Million
Q4 2023

Feb 13, 2024
BUY
$22.61 - $40.65 $5.65 Million - $10.2 Million
250,000 Added 166.67%
400,000 $15.9 Million
Q3 2023

Nov 14, 2023
BUY
$25.45 - $37.46 $1.6 Million - $2.36 Million
62,969 Added 72.35%
150,000 $4.13 Million
Q2 2023

Aug 14, 2023
BUY
$30.29 - $38.28 $1.12 Million - $1.42 Million
37,031 Added 74.06%
87,031 $2.95 Million
Q1 2023

May 15, 2023
SELL
$34.78 - $47.43 $2.09 Million - $2.85 Million
-60,000 Reduced 54.55%
50,000 $1.8 Million
Q4 2022

Feb 13, 2023
BUY
$27.78 - $45.38 $833,400 - $1.36 Million
30,000 Added 37.5%
110,000 $4.9 Million
Q3 2022

Nov 14, 2022
BUY
$22.7 - $37.57 $908,000 - $1.5 Million
40,000 Added 100.0%
80,000 $2.25 Million
Q2 2022

Aug 12, 2022
SELL
$20.5 - $37.33 $1.74 Million - $3.17 Million
-85,000 Reduced 68.0%
40,000 $1.08 Million
Q1 2022

May 13, 2022
BUY
$27.64 - $39.32 $691,000 - $983,000
25,000 Added 25.0%
125,000 $4.26 Million
Q4 2021

Feb 11, 2022
BUY
$35.68 - $56.27 $2.14 Million - $3.37 Million
59,846 Added 149.04%
100,000 $3.86 Million
Q3 2021

Nov 12, 2021
SELL
$28.95 - $55.99 $285,041 - $551,277
-9,846 Reduced 19.69%
40,154 $2.17 Million
Q2 2021

Aug 13, 2021
SELL
$20.71 - $35.37 $1.66 Million - $2.83 Million
-80,000 Reduced 61.54%
50,000 $1.67 Million
Q1 2021

May 14, 2021
BUY
$16.19 - $29.91 $890,450 - $1.65 Million
55,000 Added 73.33%
130,000 $2.68 Million
Q4 2020

Feb 12, 2021
BUY
$14.99 - $22.75 $1.12 Million - $1.71 Million
75,000 New
75,000 $1.31 Million

Others Institutions Holding CLDX

# of Institutions
207
Shares Held
67.3M
Call Options Held
1.69M
Put Options Held
980K
View Full List

About Celldex Therapeutics, Inc.

CLDX Quotes by TradingView
  • Ticker CLDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,772,400
  • Market Cap $1.19B
  • Description
  • Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...
More about CLDX
Track This Portfolio

Track Affinity Asset Advisors, LLC Portfolio

Follow Affinity Asset Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Affinity Asset Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Affinity Asset Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email